Primary Record
Trilostane
- In stock
- 3,370 g
- Purity
- 99.3 %
- CAS
- 13647-35-3
Compound Identifiers & Properties
- CAS
- 13647-35-3
- PubChem CID
- 656583
- SMILES
- C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CC[C@]45[C@@]3(CC(=C([C@H]4O5)O)C#N)C
- Canonical SMILES
- C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4C(O)=C(C#N)C[C@]35C)[C@@H]1CC[C@@H]2O
Names & Synonyms
- Trilostane
- Modrenal
- Modrastane
- Vetoryl
- Desopan
- Trilostano
- 13647-35-3
- Trilostanum
- Modrefen
- Modrenal (TN)
- Desopan (TN)
- Win-24540
- Vetoryl, Trilostane
- Vetoryl (TN)
- Trilostane (Standard)
- Trilostane (JAN/USAN)
- Trilostanum [INN-Latin]
- VETORYL CAPSULES
- L0FPV48Q5R
- Trilostano [INN-Spanish]
- RefChem:56170
- TRILOSTANE [MI]
- UNII-L0FPV48Q5R
- DTXSID9023706
- AC1LCV8M
- C20H27NO3
- TRILOSTANE [INN]
- TRILOSTANE [JAN]
- TRILOSTANE [USAN]
- WIN 24,540
- Win 24540
- TRILOSTANE [VANDF]
- CHEBI:32260
- D03XOC
- SCHEMBL7517
- TRILOSTANE [MART.]
- DTXCID103706
- TRILOSTANE [WHO-DD]
- MFCD00199295
- KVJXBPDAXMEYOA-CXANFOAXSA-N
- GTPL6850
- HY 1
- orb1308537
- Trilostane - Bio-X trade mark
- Trilostane [USAN:INN:BAN:JAN]
- TRILOSTANE [GREEN BOOK]
- Trilostane, 99% - 1G 1g
- CHEMBL1200907
- NSC-758904
- TRILOSTANE [ORANGE BOOK]
- Trilostane, >=98% (HPLC)
- CTK8G3608
- EINECS 237-133-0
- AOB5601
- WIN 24450
- GLXC-06572
- HMS3884A15
- Trilostane [USAN:BAN:INN:JAN]
- BCP04132
- WIN24540
- Tox21_112454
- Tox21_302406
- AC-927
- BDBM50247882
- C20-H27-N-O3
- CID656583
- EBC-11126
- HY-14281R
- s1404
- AKOS015964043
- AKOS032947221
- Tox21_112454_1
- Trilostane(Win 24540; Modrastane)?
- ZINC100038546
- 5-BROMO-3-FLUOROPYRIDIN-2-OL
- ACN-037303
- CB11682
- CCG-267803
- CID:656583
- CS-1707
- DB01108
- FT28510
- KS-1414
- NE46397
- NSC 758904
- NCGC00167450-01
- NCGC00255201-01
- NCGC00274061-01
- AN-15427
- BC213678
- BT300134
- HY-14281
- SC-18945
- SID:53789389
- SY046020
- BCP0726000098
- AB0008433
- AB2000090
- Androst-2-ene-2-carbonitrile, 4,5-epoxy-3,17-dihydroxy-, (4alpha,5alpha,17beta)-
- CAS-13647-35-3
- J108.016D
- A4348
- FT-0654281
- NS00018304
- C12580
- D01180
- EN300-122374
- 4,5-epoxy-17-hydroxy-3-oxoandrostane-2-carbonitrile
- 42179-EP2270008A1
- 42179-EP2292617A1
- 42179-EP2298768A1
- 42179-EP2311808A1
- 42179-EP2311829A1
- AB01274788-01
- AB01274788_02
- 4alpha,5-Epoxy-3,17beta-dihydroxy-5alpha-androst-2-ene-2-carbonitrile
- 647T353
- A886681
- C009954
- Q907313
- 4alpha,5-epoxy-17beta-hydroxy-3-oxoandrostane-2-carbonitrile
- (1aR,4aR,4bS,6aS,7S,9aS,9bS,11aS)-2,7-dihydroxy-4a,6a-dimethyl-1a,4,4a,4b,5,6,6a,7,8,9,9a,9b,10,11-tetradecahydrocyclopenta[7,8]phenanthro[1,10a-b]oxirene-3-carbonitrile
- (1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadec-4-ene-4-carbonitrile
- Androst-2-ene-2-carbonitrile, 4,5-epoxy-3,17-dihydroxy-, (4a,5a,17b)-
- Z1541759903
- 2Alpha-cyano-4alpha,5alpha-epoxyandrostan-17beta-ol-3-one
- 4-alpha,5-Epoxy-3,17-dihydroxy-5-alpha-androst-2-ene-2-carbonitrile
- B0084-057927
- Trilostane; 13647-35-3; Vetoryl; Modrenal; Modrastane
- (1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.0^{2,8}.0^{6,8}.0^{12,16}]octadec-4-ene-4-carbonitrile
- (4alpha,5alpha,17beta)-3,17-dihydroxy-4,5-epoxyandrost-2-ene-2-carbonitrile
- 3,17beta-dihydroxy-4alpha,5-epoxy-5alpha-androst-2-ene-2-carbonitrile
- (2-alpha,4-alpha,5-alpha,17-beta)-4,5-Epoxy-17-hydroxy-3-oxoandrostane-2-carbonitrile
- 4-alpha-5-Epoxy-17-beta-hydroxy-3-oxo-5-alpha-androstane-2-alpha-carbonitrile
- Androst-2-ene-2-carbonitrile, 4,5-epoxy-3,17-dihydroxy-, (4.alpha.,5.alpha.,17.beta.)-
- Androstane-2-carbonitrile, 4,5-epoxy-17-hydroxy-3-oxo-, (2-alpha,4-alpha,5-alpha,17-beta)-
- (1aR,4aR,4bS,6aS,7S,9aS,9bS,11aS)-2,7-dihydroxy-4a,6a-dimethyl-1a,4,4a,4b,5,6,6a,7,8,9,9a,9b,10,11-tetradecahydrocyclopenta[7,8]phenanthro[1,10a-b]oxirene-3-carbonitrile.
- 3,17beta-Dihydroxy-4alpha,5alpha-4,5-epoxyandrost-2-ene-2-carbonitrile
- 4alpha,5-Epoxy-3,17beta-dihydroxy-5alpha-androstan-2-ene-2-carbonitrile
- (2-alpha,4-alpha,5-alpha,17-beta)-4,5-epoxy-17-hydroxy-3-oxoandrostane-2-car
- (4-alpha,5-alpha,17-beta)-4,5-Epoxy-3,17-dihydroxyandrost-2-ene-2-carbonitrile
- (4Alpha,5alpha,17beta)-4,5-epoxy-3,17-dihydroxyandrost-2-ene-2-carbonitrile
- 5-alpha-ANDROSTANE-2-alpha-CARBONITRILE, 4-alpha,5-EPOXY-17-beta-HYDROXY-3-OXO-
- Androst-2-ene-2-carbonitrile, 4,5-epoxy-3,17-dihydroxy-, (4|A,5|A,17|A)-
- (1S,2R,6R,8S,11S,12S,15S,16S)-2,16-dimethyl-5,15-bis(oxidanyl)-7-oxapentacyclo[9.7.0.02,8.06,8.012,16]octadec-4-ene-4-carbonitrile
- (1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo(9.7.0.0^(2,8).0^(6,8).0^(12,16))octadec-4-ene-4-carbonitrile
- (1S,2R,6R,8S,11S,12S,15S,16S)-5,15-dihydroxy-2,16-dimethyl-7-oxapentacyclo[9.7.0.0?,?.0?,?.0??,??]octadec-4-ene-4-carbonitrile
- 237-133-0
- Desopan; Modrastane; Modrefen; Modrenal; Trilostane; Vetoryl; Win 24540; Androst-2-ene-2-carbonitrile, 4,5-epoxy-3,17-dihydroxy-, (4alpha,5alpha,17beta)-